Posted in | News

Draeger Unveils Advanced Infinity Acute Care Monitoring Solution

Draeger declared the VG2 release of its innovative Infinity Acute Care System monitoring solution.

It provides wireless surveillance, land ambulance transport, interoperability with ventilation systems of Draeger, and Masimo rainbow SET technology. Draeger is a monitoring vendor that delivers a full line of Masimo's rainbow SET noninvasive Pulse CO-Oximetry measurements that promote safety and cost-efficiency in hospitals.

The monitoring solution includes a handheld Infinity M540 patient monitor equipped to the Draeger Medical Cockpit. The M540 enables consistent transition from the bedside to wireless transport. The vital signs data from M540 has been integrated into the Medical Cockpit along with networked information including lab results, patient history, and diagnostic images. Additionally, networked clinical information will be integrated into single widescreen display at the point of care.

With the help of the VG2 release, the ventilation parameters from Draeger ventilators will be displayed on the Medical Cockpit and transmitted across the network.

This fully networked solution enables a single monitor to escort the patient safely along the care pathway. While being undocked at the bedside, Infinity M540 will automatically turn to wireless, thereby broadcasting patient’s vital signs data to the Infinity Network giving rise to continual monitoring at the time of transport on the Infinity CentralStation. It also supports time-critical decision making by directing the flow of patient information within the hospital and beyond.

The Infinity M540 uses Masimo rainbow SET technology. Masimo rainbow SET measures SpO(2), total hemoglobin (SpHb), methemoglobin (SpMet), pulse rate, perfusion index (PI), oxygen content (SpOC), Pleth Variability Index (PVI), and carboxyhemoglobin (SpCO).

Monitoring SpHb enables clinicians to quickly evaluate the hemoglobin level of a patient. It helps minimize unwanted blood transfusions and associated expenditures. The SpCO and SpMet facilitate precise measurement of potentially life-threatening carbon monoxide (CO) and methemoglobin levels in the blood. PVI enables clinicians to examine a patient's fluid responsiveness and volume status.

Masimo rainbow SET technology provides instant clinical information, minimizing the cost of expensive lab tests and the risk of cross-contamination and blood exposure.

Draeger Medical Systems develops the Infinity Acute Care System monitoring solution.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Masimo Corporation. (2019, February 24). Draeger Unveils Advanced Infinity Acute Care Monitoring Solution. AZoSensors. Retrieved on July 23, 2024 from

  • MLA

    Masimo Corporation. "Draeger Unveils Advanced Infinity Acute Care Monitoring Solution". AZoSensors. 23 July 2024. <>.

  • Chicago

    Masimo Corporation. "Draeger Unveils Advanced Infinity Acute Care Monitoring Solution". AZoSensors. (accessed July 23, 2024).

  • Harvard

    Masimo Corporation. 2019. Draeger Unveils Advanced Infinity Acute Care Monitoring Solution. AZoSensors, viewed 23 July 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.